Patents by Inventor Bong-Jun Cho

Bong-Jun Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for accelerating cell proliferation comprising erythropoietin-derived peptide
    Patent number: 11987608
    Abstract: Provided is a composition for accelerating cell proliferation, including an erythropoietin-derived peptide as an active ingredient. Due to having a simpler structure than that of the existing natural human erythropoietin, the composition easily passes through the tissue-blood barrier, exhibits excellent cell protective activity, does not cause side effects of cell proliferation, and improves a hematopoietic function. Accordingly, the composition is used in the treatment or prevention of an anemic disorder.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: May 21, 2024
    Assignee: SYLUS CO., LTD.
    Inventors: Che Il Moon, So Yeon Kim, Seung Jun Yoo, Bong Ki Cho
  • Modulation of radiation response using microrna
    Patent number: 8980863
    Abstract: The present invention relates to a technology of enhancing sensitivity to radiotherapy using microRNA, more particularly to a radiosensitizer composition comprising at least one selected from the group consisting of microRNA-26b, microRNA-203 and microRNA-200c, an anticancer supplement, and a method for enhancing sensitivity to radiotherapy of cancer cells using the same.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: March 17, 2015
    Assignee: SNU R&DB Foundation
    Inventors: In-Ah Kim, Bong-Jun Cho, Eun Jung Choi, Hans Hyonchang Kim, David J. Lee
  • MODULATION OF RADIATION RESPONSE USING MICRORNA
    Publication number: 20140194488
    Abstract: The present invention relates to a technology of enhancing sensitivity to radiotherapy using microRNA, more particularly to a radiosensitizer composition comprising at least one selected from the group consisting of microRNA-26b, microRNA-203 and microRNA-200c, an anticancer supplement, and a method for enhancing sensitivity to radiotherapy of cancer cells using the same.
    Type: Application
    Filed: May 7, 2013
    Publication date: July 10, 2014
    Inventors: In-Ah KIM, Bong-Jun Cho, Eun Jung Choi, Hans Hyonchang Kim, David J. Lee